Literature DB >> 3779719

Silent myocardial ischemia and infarction: insights from the Framingham Study.

W B Kannel.   

Abstract

More than one in four myocardial infarctions that occurred over 30 years in the Framingham Study were detected only because of routine biennial electrocardiographic examinations. Of these, almost half were completely silent. The fraction of infarctions unrecognized was higher in women (35 per cent) than in men (28 per cent). Such infarcts were uncommon in persons with angina and recurrent infarctions. Unrecognized infarctions were as likely as recognized ones to result in eventual death, heart failure, or strokes. Thus, unrecognized infarctions are common and have as serious a prognosis as typically symptomatic infarctions.

Entities:  

Mesh:

Year:  1986        PMID: 3779719

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  17 in total

1.  Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.

Authors:  Waqas T Qureshi; Zhu-Ming Zhang; Patricia P Chang; Wayne D Rosamond; Dalane W Kitzman; Lynne E Wagenknecht; Elsayed Z Soliman
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

2.  Is silent myocardial infarction more common in women with type 2 diabetes than in men?

Authors:  Monica C Stiles; Elizabeth R Seaquist; Jean Francois Yale; Jennifer B Green; Lois Anne Katz; Sarah Kempainen; Laney S Light; Patricia V Pepper; Zhu-Ming Zhang; Elsayed Z Soliman
Journal:  J Diabetes Complications       Date:  2012-03-24       Impact factor: 2.852

3.  Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998.

Authors:  Jaume Marrugat; Roberto Elosua; Elena Aldasoro; María José Tormo; Hermelinda Vanaclocha; Antonio Segura; Miquel Fiol; Concepción Moreno-Iribas; Gloria Pérez; José María Arteagoitia; Lluis Cirera; Adolfo Cabadés; Gema Vega; José Ignacio Ayestarán; Vega García; Iraida Hurtado-de-Saracho; José García; Oscar Zurriaga; Javier Muñiz; Joan Sala
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension.

Authors:  Domenico Rendina; Renato Ippolito; Gianpaolo De Filippo; Riccardo Muscariello; Daniela De Palma; Silvana De Bonis; Michele Schiano di Cola; Domenico Benvenuto; Maurizio Galderisi; Pasquale Strazzullo; Ferruccio Galletti
Journal:  Intern Emerg Med       Date:  2016-08-26       Impact factor: 3.397

Review 5.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

6.  An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.

Authors:  J Marrugat; R D'Agostino; L Sullivan; R Elosua; P Wilson; J Ordovas; P Solanas; F Cordón; R Ramos; J Sala; R Masiá; W B Kannel
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

Review 7.  Risk stratification after myocardial infarction: role of electrical instability, ischemia, and left ventricular function.

Authors:  A Bayés-de-Luna; X Viñolas; J Guindo; A Bayés-Genis
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 8.  Diagnostic technology in cardiovascular disease: review of noninvasive methods for population studies.

Authors:  R F Gillum
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 9.  Diagnosing and characterizing coronary artery disease in women: developments in noninvasive and invasive imaging techniques.

Authors:  Vivian G Ng; Stephanie Meller; Suchith Shetty; Alexandra J Lansky
Journal:  J Cardiovasc Transl Res       Date:  2013-08-06       Impact factor: 4.132

10.  Radial Pulse Spectrum Analysis as Risk Markers to Improve the Risk Stratification of Silent Myocardial Ischemia in Type 2 Diabetic Patients.

Authors:  Chi-Wei Chang; Kuo-Meng Liao; Ying-Chun Chen; Sheng-Hung Wang; Ming-Yie Jan; Gin-Chung Wang
Journal:  IEEE J Transl Eng Health Med       Date:  2018-09-20       Impact factor: 3.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.